On June 14, 2021 Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic platform, reported that its Chief Executive Officer, Dr. Gerrit Dispersyn, will participate in the AGP Summer Healthcare Symposium and a fireside chat hosted by H.C. Wainwright which are being held virtually on June 17, 2021 and June 22, 2021, respectively (Press release, Phio Pharmaceuticals, JUN 14, 2021, View Source [SID1234583962]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Logo – View Source

AGP Summer Healthcare Symposium:
Date: June 17, 2021
Event: One-on-one Meetings – organized through AGP representatives

H.C. Wainwright Fireside Chat:
Date: June 22, 2021
Time: 10:00 am EST
Webcast: Register Here

Interested parties may also access the H.C. Wainwright Fireside Chat webcast through the "Investors – Events and Presentations" section of the Company’s website. The webcast will be archived and available on the Company’s website for 90 days.